Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed Nov 23, 2020
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Award
Common Stock
2020-11-20$3.00/sh+1,305$3,915→ 41,305 total
Footnotes (1)
- [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).